Philip Cohen

8.5k total citations · 2 hit papers
18 papers, 7.2k citations indexed

About

Philip Cohen is a scholar working on Molecular Biology, Cell Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Philip Cohen has authored 18 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cell Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Philip Cohen's work include Muscle Physiology and Disorders (5 papers), Melanoma and MAPK Pathways (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Philip Cohen is often cited by papers focused on Muscle Physiology and Disorders (5 papers), Melanoma and MAPK Pathways (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Philip Cohen collaborates with scholars based in United Kingdom, United States and Switzerland. Philip Cohen's co-authors include Darren A.E. Cross, Dario R. Alessi, Brian A. Hemmings, Yasumasa Tsukitani, Charles F.B. Holmes, Paul Dent, F. Barry Caudwell, Sara Nakielny, Patricia T.W. Cohen and Peter Watt and has published in prestigious journals such as Nature, Oncogene and Trends in Biochemical Sciences.

In The Last Decade

Philip Cohen

18 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

1995 4.4k citations Darren A.E. Cross, Dario R. Alessi et al. Nature profile →
Okadaic acid: a new probe for the study of cellular regulation

1990 1.3k citations Philip Cohen, Charles F.B. Holmes et al. Trends in Biochemical Sciences profile →

Peers

Countries citing papers authored by Philip Cohen

Since Specialization

Citations

This map shows the geographic impact of Philip Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Cohen more than expected).

Fields of papers citing papers by Philip Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Cohen. The network helps show where Philip Cohen may publish in the future.

Co-authorship network of co-authors of Philip Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Cohen. A scholar is included among the top collaborators of Philip Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Cohen. Philip Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Involvement of Mitogen-Activated Protein Kinase Homologues in the Regulation of Lipopolysaccharide-Mediated Induction of Cyclo-oxygenase-2 but not Nitric Oxide Synthase in RAW 264.7 Macrophages 1999 ·Cellular Signalling ·Andrew Paul, Ana Cuenda, Clare Bryant, (unknown), Edwin R. Chilvers, Philip Cohen, Gwyn W. Gould, Robin Plevin	100
2	Effect of SB 203580 on the activity of c-Raf in vitro and in vivo 1999 ·Oncogene ·(unknown), Michel Goedert, Philip Hedge, Philip Cohen	132
3	Engineering protein kinases with distinct nucleotide specificities and inhibitor sensitivities by mutation of a single amino acid 1998 ·Chemistry & Biology ·Philip Cohen, Michel Goedert	14
4	The major myosin phosphatase in skeletal muscle is a complex between the β‐isoform of protein phosphatase 1 and the MYPT2 gene product 1998 ·FEBS Letters ·Greg B. G. Moorhead, (unknown), (unknown), Philip Cohen	51
5	PPP1R6, a novel member of the family of glycogen‐targetting subunits of protein phosphatase 1 1997 ·FEBS Letters ·Christopher G. Armstrong, Gareth J. Browne, Philip Cohen, Patricia T.W. Cohen	90
6	Identification of the Regions on the M₁₁₀ Subunit of Protein Phosphatase 1M That Interact with the M₂₁ Subunit and with Myosin 1997 ·European Journal of Biochemistry ·(unknown), Philip Cohen, (unknown), Mao Xiang Chen, Yu Hua Chen, Patricia T.W. Cohen	78
7	Further evidence that inhibitor‐2 acts like a chaperone to fold PP1 into its native conformation 1996 ·FEBS Letters ·Carol MacKintosh, Andrew J. Garton, (unknown), D. Barford, Patricia T.W. Cohen, Nicholas K. Tonks, Philip Cohen	52
8	The cyanobacterial toxin microcystin binds covalently to cysteine‐273 on protein phosphatase 1 1995 ·FEBS Letters ·Robert W. MacKintosh, Kevin N. Dalby, David G. Campbell, Patricia T.W. Cohen, Philip Cohen, Carol MacKintosh	230
9	Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B breakdown → 1995 ·Nature ·Darren A.E. Cross, Dario R. Alessi, Philip Cohen, (unknown), Brian A. Hemmings	4369
10	Comparison of the specificities of p70 S6 kinase and MAPKAP kinase‐1 identifies a relatively specific substrate for p70 S6 kinase: the N‐terminal kinase domain of MAPKAP kinase‐1 is essential for peptide phosphorylation 1995 ·FEBS Letters ·Ian Leighton, Kevin N. Dalby, F. Barry Caudwell, Patricia T.W. Cohen, Philip Cohen, (unknown), (unknown)	116
11	Activation of the MAP kinase homologue RK requires the phosphorylation of Thr‐180 and Tyr‐182 and both residues are phosphorylated in chemically stressed KB cells 1995 ·FEBS Letters ·Yair N. Doza, Ana Cuenda, Gareth M. Thomas, Philip Cohen, Ángel R. Nebreda	72
12	A myofibrillar protein phosphatase from rabbit skeletal muscle contains the β isoform of protein phosphatase‐1 complexed to a regulatory subunit which greatly enhances the dephosphorylation of myosin 1992 ·European Journal of Biochemistry ·Paul Dent, Lindsay K. MacDougall, Carol MacKintosh, David G. Campbell, Philip Cohen	50
13	The molecular mechanism by which adrenalin inhibits glycogen synthesis 1991 ·European Journal of Biochemistry ·Sara Nakielny, David G. Campbell, Philip Cohen	74
14	Targetting of protein phosphatase 1 to the sarcoplasmic reticulum of rabbit skeletal muscle by a protein that is very similar or identical to the G subunit that directs the enzyme to glycogen 1990 ·European Journal of Biochemistry ·Michael J. Hubbard, Paul Dent, Carl Smythe, Philip Cohen	66
15	Okadaic acid: a new probe for the study of cellular regulation breakdown → 1990 ·Trends in Biochemical Sciences ·Philip Cohen, Charles F.B. Holmes, Yasumasa Tsukitani	1251
16	Identification of three in vivo phosphorylation sites on the glycogen‐binding subunit of protein phosphatase 1 from rabbit skeletal muscle, and their response to adrenaline 1990 ·FEBS Letters ·Paul Dent, David G. Campbell, F. Barry Caudwell, Philip Cohen	44
17	The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle 1990 ·Nature ·Paul Dent, Alain Lavoinne, Sara Nakielny, F. Barry Caudwell, Peter Watt, Philip Cohen	437
18	Ontogeny of Protein Phosphatases 1 and 2A in Developing Rat Lung 1988 ·Pediatric Research ·David Warburton, Philip Cohen	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact